Commonwealth Equity Services LLC Sells 40,935 Shares of iShares Biotechnology ETF $IBB

Commonwealth Equity Services LLC decreased its position in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 22.7% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 139,684 shares of the financial services provider’s stock after selling 40,935 shares during the period. Commonwealth Equity Services LLC owned 0.33% of iShares Biotechnology ETF worth $20,166,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Brighton Jones LLC bought a new position in shares of iShares Biotechnology ETF in the fourth quarter worth about $201,000. AQR Capital Management LLC acquired a new stake in iShares Biotechnology ETF in the 1st quarter valued at approximately $455,000. Millennium Management LLC increased its position in iShares Biotechnology ETF by 140.8% in the 1st quarter. Millennium Management LLC now owns 41,676 shares of the financial services provider’s stock worth $5,330,000 after buying an additional 143,893 shares during the period. NewEdge Advisors LLC lifted its holdings in shares of iShares Biotechnology ETF by 8.7% during the first quarter. NewEdge Advisors LLC now owns 14,984 shares of the financial services provider’s stock worth $1,917,000 after buying an additional 1,195 shares during the last quarter. Finally, WealthCare Investment Partners LLC boosted its position in shares of iShares Biotechnology ETF by 7.7% in the second quarter. WealthCare Investment Partners LLC now owns 12,938 shares of the financial services provider’s stock valued at $1,682,000 after acquiring an additional 926 shares during the period. 62.45% of the stock is owned by institutional investors and hedge funds.

iShares Biotechnology ETF Stock Performance

Shares of iShares Biotechnology ETF stock opened at $172.39 on Friday. iShares Biotechnology ETF has a 1 year low of $107.43 and a 1 year high of $179.64. The company’s fifty day simple moving average is $168.14 and its 200-day simple moving average is $149.84.

iShares Biotechnology ETF Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, December 19th. Shareholders of record on Tuesday, December 16th were given a $0.1831 dividend. The ex-dividend date was Tuesday, December 16th. This represents a $0.73 annualized dividend and a yield of 0.4%. This is a positive change from iShares Biotechnology ETF’s previous quarterly dividend of $0.08.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.